Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
Hyuntae Park, Jongmin Kim, S. Ahn, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5398-5398
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer
Yilin Lin, Xiangxiang Jing, Zhihua Chen, et al.
Theranostics (2023) Vol. 13, Iss. 13, pp. 4574-4600
Open Access | Times Cited: 27
Advances in biosensors for major depressive disorder diagnostic biomarkers
Tao Dong, Chenghui Yu, Qi Mao, et al.
Biosensors and Bioelectronics (2024) Vol. 258, pp. 116291-116291
Closed Access | Times Cited: 8
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025) Vol. 569, pp. 161-183
Closed Access | Times Cited: 1
Role of gut microbiota in depression: Understanding molecular pathways, recent research, and future direction
Deepak Rathour, Shruti Shah, Sabiya Khan, et al.
Behavioural Brain Research (2022) Vol. 436, pp. 114081-114081
Closed Access | Times Cited: 33
Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection
Miguel Á. Ortega, Oscar Fraile‐Martínez, Cielo García‐Montero, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 32
Research trend of epigenetics and depression: adolescents' research needs to strengthen
Dongfeng Yuan, Yitong Meng, Zhongzhu Ai, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
New Paradigms of Old Psychedelics in Schizophrenia
Danish Mahmood, Sattam Khulaif Alenezi, Md Jamir Anwar, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 640-640
Open Access | Times Cited: 25
Novel histone deacetylase-5 inhibitor T2943 exerts an anti-depressive effect in mice by enhancing GRID1 expression
Juan Du, Ruyun Liu, Lin Ma, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Rescuing DNMT1 fails to fully reverse the molecular and functional repercussions of its loss in mouse embryonic stem cells
Elizabeth Elder, Anthony Lemieux, Lisa‐Marie Legault, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 4
Open Access
Histone H3 lysine 9 tri-methylation is associated with pterygium
Dahee Choi, Ann-Yae Na, Seok-Won Jeoung, et al.
BMC Ophthalmology (2025) Vol. 25, Iss. 1
Open Access
Epigenetic Insights into Substance Use Disorder and Associated Psychiatric Conditions
A. Ngo, Christopher M Ahmad, Niki Gharavi Alkhansari, et al.
Complex Psychiatry (2025) Vol. 11, Iss. 1, pp. 12-36
Closed Access
Integrated analysis of the chemical-material basis and molecular mechanisms for the classic herbal formula of Lily Bulb and Rehmannia Decoction in alleviating depression
Hongxiu Zhang, Xiaoyan Xue, Jin Pan, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 26
Understanding treatment-resistant depression using “omics” techniques: A systematic review
Nare Amasi-Hartoonian, Carmine M. Pariante, Annamaria Cattaneo, et al.
Journal of Affective Disorders (2022) Vol. 318, pp. 423-455
Open Access | Times Cited: 18
Histone modification in Saccharomyces cerevisiae: A review of the current status
Kwon Young Chou, Jun-Yeong Lee, Kee‐Beom Kim, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1843-1850
Open Access | Times Cited: 10
Epigenetic Aging in Major Depressive Disorder: Clocks, Mechanisms and Therapeutic Perspectives
Muqtada Shaikh, Gaurav Doshi
European Journal of Pharmacology (2024) Vol. 978, pp. 176757-176757
Closed Access | Times Cited: 3
Molecular signatures of premature aging in Major Depression and Substance Use Disorders
Anna Onisiforou, Panos Zanos, Polymnia Georgiou
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 3
Transcriptomic decoding of regional cortical vulnerability to major depressive disorder
Jiajia Zhu, Xiao Chen, Bin Lü, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Integrative multi-omics landscape of fluoxetine action across 27 brain regions reveals global increase in energy metabolism and region-specific chromatin remodelling
Nirmala Arul Rayan, Vibhor Kumar, Jonathan Aow, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4510-4525
Open Access | Times Cited: 15
Upregulation of HDAC9 in hippocampal neurons mediates depression-like behaviours by inhibiting ANXA2 degradation
Yunjian Dai, Taofeng Wei, Yuwen Huang, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 10
Open Access | Times Cited: 8
Antidepressant and Anxiolytic Effects of L-Methionine in the WAG/Rij Rat Model of Depression Comorbid with Absence Epilepsy
K. Yu. Sarkisova, Alexandra V. Gabova, Ekaterina Fedosova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12425-12425
Open Access | Times Cited: 7
Antidepressant effect of the novel histone deacetylase-5 inhibitor T2943 in a chronic restraint stress mouse model
Juan Du, Ning Liu, Lin Ma, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116176-116176
Open Access | Times Cited: 2
Trichostatin A relieves anxiety-and depression-like symptoms in APP/PS1 mice
Qiang Su, Yu-Hua Ren, Guowei Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Comprehensive Analysis of the Differential Expression and Prognostic Value of Histone Deacetylases in Glioma
Jinwei Li, Xianlei Yan, Cong Liang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
Depressive disorder and antidepressants from an epigenetic point of view
Iris Šalamon Arčan, Katarina Kouter, Alja Videtič Paska
World Journal of Psychiatry (2022) Vol. 12, Iss. 9, pp. 1150-1168
Open Access | Times Cited: 12
Histone Deacetylase Inhibitors as Cognitive Enhancers and Modifiers of Mood and Behavior
Dilipkumar Pal, Pooja Sahu, Abhishek Kumar Mishra, et al.
Current Drug Targets (2022) Vol. 24, Iss. 9, pp. 728-750
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top